12 HR ranolazine 1000 MG Extended Release Oral Tablet [Ranexa]

RxNorm concept 860737, branded drug (sbd). Prescribable name: Ranexa 1000 MG 12HR Extended Release Oral Tablet.

RxCUI: 860737
Term type: Branded drug (SBD)
Status: Active

Request

curl https://api.healthcare.dev/v1/drugs/rxnorm/860737 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Concept

Ingredients and related concepts

Ingredients

ranolazine 35829

Other names

Ranexa 1000 MG 12 HR Extended Release Oral Tablet

Related concepts

ranolazine 1000 MG (SCDC, consists of)
ranolazine 1000 MG [Ranexa] (SBDC, consists of)
Extended Release Oral Tablet (DF, has dose form)
Ranexa (BN, has ingredient)
12 HR ranolazine 1000 MG Extended Release Oral Tablet (SCD, tradename of)

Linked data

NDCs

61958100202

NDC-11s RxNorm links to this concept; linked ones open their FDA product.

Use it

Look up 860737 from code or an agent

curl

curl https://api.healthcare.dev/v1/drugs/rxnorm/860737 \
  -H "Authorization: Bearer $HDEV_API_KEY"

MCP prompt

Using the healthcare.dev MCP server, look up RxNorm concept 860737. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.

Get a free key RxNorm docs Connect the MCP server

Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.